Polystyrene microsphere-ferritin conjugates: A robust phantom for correlation of relaxivity and size distribution

Magnetic Resonance in Medicine

Volumn 65, Issue 2, 2011, Pages 522-530

  Sukerkar, Preeti A ^a   Rezvi, Uzma G ^a   MacRenaris, Keith W ^a   Patel, Pinal C ^a   Wood, John C ^b   Meade, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

ferritin; MRI; transverse relaxation

Indexed keywords

IRON; MAGNETIC RESONANCE IMAGING; MICROSPHERES; PARTICLE SIZE; PHANTOMS; POLYSTYRENES; SIZE DISTRIBUTION; SPECTROMETERS;

DIFFERENT SIZES; FERRITIN; IRON CONCENTRATIONS; LOW-RESOLUTION NMR; POLYSTYRENE MICRO-SPHERE; PROTON RELAXATION; SIGNAL INTENSITIES; TRANSVERSE RELAXATION;

IRON DEPOSITS;

FERRITIN; IRON; POLYSTYRENE;

ARTICLE; CONJUGATE; CONTROLLED STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PH; PHANTOM; PROTEIN SYNTHESIS;

EID: 79251570268     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22627     Document Type: Article

References (37)

1. Rund D, Rachmilewitz E,. Beta-thalassemia. N Engl J Med 2005; 353: 1135-1146.
2. Pietrangelo A,. Hereditary hemochromatosisâa new look at an old disease. N Engl J Med 2004; 350: 2383-2397.
3. Franchini M,. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol 2006; 81: 202-209.
4. Lefton HB, Rosa A, Cohen M,. Diagnosis and epidemiology of cirrhosis. Med Clin North Am 2009; 93: 787-799, vii.
5. Mani H, Kleiner DE,. Liver biopsy findings in chronic hepatitis B. Hepatology 2009; 49 (5 Suppl): S61-S71.
6. Fujita N, Miyachi H, Tanaka H, Takeo M, Nakagawa N, Kobayashi Y, Iwasa M, Watanabe S, Takei Y,. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis. Cancer Epidemiol Biomarkers Prev 2009; 18: 424-432.
7. Meerang M, Nair J, Sirankapracha P, Thephinlap C, Srichairatanakool S, Arab K, Kalpravidh R, Vadolas J, Fucharoen S, Bartsch H,. Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients. Int J Cancer 2009; 125: 759-766.
8. Li H, Swiercz R, Englander EW,. Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA. J Neurochem 2009; 110: 1774-1783.
9. Anderson GJ,. Mechanisms of iron loading and toxicity. Am J Hematol 2007; 82 (12 Suppl): 1128-1131.
10. 2* methods. Magn Reson Imaging 2008; 26: 1175-1182.
11. Alexander J, Kowdley KV,. HFE-associated hereditary hemochromatosis. Genet Med 2009; 11: 307-313.
12. Berdoukas V, Chouliaras G, Moraitis P, Zannikos K, Berdoussi E, Ladis V,. The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. J Cardiovasc Magn Reson 2009; 11: 20-30.
13. Taher A, Hershko C, Cappellini MD,. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies. Br J Haematol 2009; 147: 634-640.
14. Mahal AS, Knauer CM, Gregory PB,. Bleeding after liver biopsy. West J Med 1981; 134: 11-14.
15. Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, Spengler U,. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 2003; 67: 138-145.
16. 2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 2008; 93: 1385-1388.
17. Wood JC, Fassler JD, Meade TJ,. Mimicking liver iron overload using liposomal ferritin preparations. Magn Reson Med 2004; 51: 607-611.
18. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL,. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101: 4632-4639.
19. Leung AW, Chu WC, Lam WW, Lee V, Li CK,. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. Pediatr Blood Cancer 2009; 53: 1054-1059.
20. Wood JC,. Diagnosis and management of transfusion iron overload: the role of imaging. Am J Hematol 2007; 82 (12 Suppl): 1132-1135.
21. Wood JC, Ghugre N,. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 2008; 32: 85-96.
22. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y,. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362.
23. Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia-Bengoechea M, Barrio J, Mujica F, Recondo JA,. MR quantification of hepatic iron concentration. Radiology 2004; 230: 479-484.
24. Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O,. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol 2006; 77: 145-149.
25. Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Hermine C,. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997; 168: 1205-1208.
26. Angelucci E, Giovagnoni A, Valeri G, Paci E, Ripalti M, Muretto P, McLaren C, Brittenham GM, Lucarelli G,. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood 1997; 90: 4736-4742.
27. Brittenham GM, Badman DG,. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003; 101: 15-19.
28. Iancu TC, Deugnier Y, Halliday JW, Powell LW, Brissot P,. Ultrastructural sequences during liver iron overload in genetic hemochromatosis. J Hepatol 1997; 27: 628-638.
29. Richter GW,. Studies of iron overload. Rat liver siderosome ferritin. Lab Invest 1984; 50: 26-35.
30. Gossuin Y, Gillis P, Muller RN, Hocq A,. Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo. NMR Biomed 2007; 20: 749-756.
31. Gossuin Y, Burtea C, Monseux A, Toubeau G, Roch A, Muller RN, Gillis P,. Ferritin-induced relaxation in tissues: an in vitro study. J Magn Reson Imaging 2004; 20: 690-696.
32. Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A,. Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1: 299-310.
33. Hocq A, Brouette N, Saussez S, Luhmer M, Gillis P, Goussuin Y,. Variable-field relaxometry of iron-containing human tissues: a preliminary study. Contrast Media Mol Imaging 2009; 4: 157-164.
34. Gossuin Y, Roch A, Muller RN, Gillis P, Lo Bue F,. Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn Reson Med 2002; 48: 959-964.
35. Ghugre NR,. Calibration of iron-mediated MRI relaxation by Monte Carlo modeling. Doctoral Thesis, University of Southern California; 2008. p 73.
36. Ghugre NR, Coates TD, Nelson MD, Wood JC,. Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005; 54: 1185-1193.
37. Jensen JH, Chandra R,. Theory of nonexponential decay in liver with iron overload or superparamagnetic iron oxide particles. Magn Reson Imaging 2002; 47: 1131-1138.